In a decision closely watched by parents and teachers across America, a panel of independent experts advising the US Food and Drug Administration on Tuesday recommended that regulators authorize Pfizer’s Covid-19 vaccine for 5-year-olds to 11-year-olds, a group that numbers 28 million.
In a decision closely watched by parents and teachers across America, a panel of independent experts advising the US Food and Drug Administration on Tuesday recommended that regulators authorize Pfizer’s Covid-19 vaccine for 5-year-olds to 11-year-olds, a group that numbers 28 million.
